Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea
· Delayed Price · Currency is KRW 4,075.00
+40.00 (0.99%)
At close: Mar 6, 2026
Dx & Vx Revenue
Dx & Vx had revenue of 5.61B KRW in the quarter ending September 30, 2025, a decrease of -22.69%. This brings the company's revenue in the last twelve months to 29.47B, down -14.74% year-over-year. In the year 2024, Dx & Vx had annual revenue of 33.95B, down -17.69%.
Revenue (ttm)
29.47B
Revenue Growth
-14.74%
P/S Ratio
13.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
396.18B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| 3billion | 9.78B |
| GENINUS | 8.81B |
| Cytogen | 25.09B |
| HLB Panagene | 14.29B |
| Green Cross Medical Science | 111.12B |
| Protia | 13.52B |
| Seoulin Bioscience | 76.74B |
| GeneMatrix | 4.72B |